Michael R. Dunn

Michael R. Dunn has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Global Future City Holding Inc. and US-China Biomedical Technology, Inc. In total, 20 filings cover trades dated from 26 August 2009 to 28 July 2017.

Both buying and selling appear: 2 purchases worth €198k, against 9 sales worth €203k. The net balance comes to €5,065 on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. So far in 2017, the count stands at 2 purchases and no sales.

The latest filing, published on 8 August 2017, reports a transaction in US-China Biomedical Technology, Inc. The last purchase on record was published on 8 August 2017, which is 3,379 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.